본문 바로가기
KERD
논문KCI 등재

유방암종에서 p130Cas 및 FHIT의 발현과 예후인자와의 상관성 연구

Expressions of p130Cas and FHIT, and Their Relationships with Prognostic Factors for Breast Carcinomas

유진영|강석진|강창석|정지한|최현주
대한병리학회|2005.02|Journal of Pathology and Translational Medicine|제39권 제1호|pp. 41-47

2

조회

0

다운로드

0

인용

0

참고문헌

주제분류병리학

초록

Abstract

Background : BCAR1/p130Cas protein is the human homologue of rat p130Cas protein, and it is a docking protein involved in the intracellular signaling pathways. This protein also causes the proliferating human breast cancer cells to be resistant to antiestrogen drugs. The fragile histidine triad (FHIT) protein is presumed to have a tumor suppressor function in a number of human tumors. The aim of this study was to investigate expressions of p130Cas and FHIT in breast carcinomas and to evaluate their relationship with the clinicopathological prognostic factors. Methods : A total of 93 cases of invasive breast carcinomas was retrospectively reviewed. The expressions of p130Cas and FHIT were examined by immunohistochemical methods. Results : p130Cas expression was observed in all breast carcinomas: p130Cas immunoreactivity was strongly positive in 39 cases (41.9%), moderately positive in 49 cases (52.7%) and weakly positive in 5 cases (5.4%) of 93 cases. It was statistically correlated with the p53 (p=0.035) and c-erbB-2 (p=0.024) expressions. The FHIT protein expression was markedly reduced or completely negative in 59 cases (63.4%), but it was not correlated with the clinicopathological prognostic factors. There was no significant correlation between p130Cas and FHIT expressions. Conclusions : This study seems to provide meager information on whether these proteins may be useful prognostic factors, and so this topic needs further study.

참고문헌 (30)

  1. "Ministry of Health and WelfareRepublic of Korea 2002 Annual Report of the Korea Central CancerRegistry" (2003)
  2. "Integrin-mediated cell adhesionpromotes tyrosine phosphorylation of p130Cas,a Src homology3-containing molecule having multiple Src homology 2-bindingmotifs", 270, pp.15398~402 (1995)
  3. "Transmembrane tyrosine phosphataseLAR induces apoptosis by dephosphorylating and destabilizingp130Cas", 4, pp.185~96 (1999)
  4. "Tumor suppressor PTENinhibition of cell invasion,migration,and growth differential involvementof focal adhesion kinase and p130Cas", 59, pp.442~9 (1999)
  5. "Tyrosine phosphorylation ofp130Cas is involved in actin organization in osteoclasts", 273, pp.11144~9
  6. "Epidermal growth factor modulates tyrosinephosphorylation of p130Cas-involvement of phosphatidylinositol3'-kinase and actin cytoskeleton", 272, pp.25993~8 (1997)
  7. "Cardiovascular anomaly,impairedactin bundling and resistance to Src-induced transformationin mice lacking p130Cas", 19, pp.361~5 (1998)
  8. "Identification of anamino-terminal substrate-binding domain in the Yersinia tyrosinephosphatase that is required for efficient recognition of focal adhesiontargets", 29, pp.1263~74 (1998)
  9. "BCAR1,a humanhomologue of the adapter protein p130cas and antiestrogen resistancein breast cancer cells", 92, pp.112~20 (2000)
  10. "is abnormal in digestive tract cancers", 84, pp.587~97
  11. "Reduced Fhitexpression in familial and sporadic breast carcinomas", 59, pp.2682~9
  12. "Expression of reciprocal hydrid transcripts of HMGIC and FHIT ina pleomorphic adenoma of the parotid gland", 57, pp.13~7 (1997)
  13. "Absence or reduction of Fhit expression in most clearcell renal carcinomas", 58, pp.2946~51 (1998)
  14. "Abnormal Fhit expression inmalignant and premalignant lesions of the cervix", 59, pp.5270~4 (1999)
  15. "The FHIT gene is expressed in pancreatic ductular cells and is alteredin pancreatic cancers", 59, pp.1308~14 (1999)
  16. "Pathological prognostic factors in breast cancer The value of histological grade in breast cancer experience froma large study with long-term follow-up", pp.403~10
  17. "The pathology of invasive breast cancer A Syllabus derived fromfindings of the National Surgical Adjuvant Breast Project", 36, pp.1~85
  18. "Tamoxifen forearly breast cancer:an overview of the randomised trials", 351, pp.1451~67 (1998)
  19. "Assessment of response to therapy in advanced breast cancer:a project of the Programme on Clinical Oncology of the InternationalUnion Against Cancer,Geneva,Switzerland", 39, pp.1289~94 (1977)
  20. "Induction of antiestrogen resistance in human breast cancercells by random insertional mutagenesis using defective retroviruses:identification of bcar-1,a common integration site", 7, pp.870~8
  21. "Identification of a novel breast-canceranti-estrogen-resistance(BCAR2)locus by cell-fusion-mediated genetransfer in human breast-cancer cells", 72, pp.700~5 (1997)
  22. "Identification of BCAR3 by a random searchfor genes involved in antiestrogen resistance of human breast cancercells", 17, pp.2799~808 (1998)
  23. "Bcar1", p130cas proteinand primary breast cancer:prognosis and response to tamoxifentreatment, 2000, pp.92, 120~7
  24. "Agonist-stimulatedcytoskeletal reorganization and signal transduction at focaladhesions in vascular smooth muscle cells require c-Src", 103, pp.789~97
  25. "Acquired tamoxifen resistance:correlation with reduced breasttumor levels of tamoxifen and isomerization of trans-4-hydroxyta-moxifen", 83, pp.1477~82 (1991)
  26. "The identification of p130cas-binding proteins and their role in cellulartransformation", 12, pp.2467~72 (1996)
  27. "Association ofPTP-PEST with the SH3 domain of p130cas;a novel mechanism ofprotein tyrosine phosphatase substrate recognition", 15, pp.877~85 (1997)
  28. "The expression of fhitprotein is related inversely to disease progression in patients withbreast carcinoma", 88, pp.1378~83 (2000)
  29. "Restoration of fragile histidinetriad(FHIT)expression induces apoptosis and suppresses tumorigenicityin breast cancer cell lines", 63, pp.1183~7 (2003)
  30. "Fhit expression in gastricadenocarcinoma:correlation with disease stage and survival", 88, pp.24~34 (2000)

관련 논문AI추천

유방암종에서 p27kip1 단백의 세포 내 발현 위치와 예후와의 관련성김대철, 조세헌, 홍숙희, 홍영습대한병리학회 · Journal of Pathology and Translational Medicine2006 · 제40권 제3호유방암종의 MMP-2와 MMP-9 발현과 예후 인자와의 연관성박설미, 윤혜경대한병리학회 · Journal of Pathology and Translational Medicine2004 · 제38권 제2호유방의 침윤성 관암종에서 Anaphase-promoting Complex의 발현과 예후 인자와의 관계강엽, 박광화, 엄민섭, 이광길, 이상엽, 정순희대한병리학회 · Journal of Pathology and Translational Medicine2003 · 제37권 제1호위샘암종에서 FHIT와 p21의 발현강석진, 강창석, 김병기, 유진영, 최현주대한병리학회 · Journal of Pathology and Translational Medicine2004 · 제38권 제1호유방 병변의 악성 진행에 따른 Survivin 단백 발현강석진, 강창석, 유진영, 이교영, 이은정, 정지한, 정찬권, 최현주대한병리학회 · Journal of Pathology and Translational Medicine2007 · 제41권 제4호유방의 침윤성 관암종에서 p21, p53 및 bcl-2 단백의 발현문형배, 윤기중, 조향정대한병리학회 · Journal of Pathology and Translational Medicine2003 · 제37권 제6호

이 간행물의 다른 논문 (10건)

PTEN and p53 Mutations in Endometrial Carcinomas최재성, 노흥태, 이혜경, 이윤이, 나선영, 서광선pp. 1-8Microsatellite Instability and Mismatch Repair Protein (hMLH1, hMSH2) Expression in Intrahepatic Cholangiocarcinoma김우호, 강윤경pp. 9-14유방조직에서 티로신 활성효소 수용체인 EphA2, c-met 및 c-erbB-2의 발현박영의, 민수기, 염범우, 조현득, 박혜림, 조성진, 신형식pp. 15-22한국인 희소돌기아교세포종의 1p/19q 이형접합소실 검사에 적합한 현미부수체 표지자김호근, 김태승, 김세훈pp. 23-33자궁내 발달지연과 정상 말기임신 태반에서의 Telomerase 활성도와 MIB-1 및 Fas, Fas Ligand 발현차이에 관한 연구홍성란, 양문호, 전이경pp. 34-40
원문 보기